Results 271 to 280 of about 2,929,870 (356)

Visual perception and geographical education: an investigation into possible visual differences between urban and rural children in viewing colour slides and methods of collecting and analysing visual perception data

, 1983
Philip Warwick
openalex   +1 more source

Interaction of HS1BP3 with cortactin modulates TKS5 localisation, cell secretion and cancer malignancy

Molecular Oncology, EarlyView.
Here, we demonstrate that HS1BP3 interacts with Cortactin through a proline‐rich region (PRR3.1) and show that this interaction, and HS1BP3 itself, promote cancer cell proliferation and invasion. Inhibition of this interaction leads to build‐up of TKS5 in multivesicular endosomes and altered secretion of CD63 and CD9, providing an explanation for the ...
Arja Arnesen Løchen, Kristiane Søreng, Chiara Veroni, Laura Trachsel‐Moncho, Nagham Asp, Robin Gaupset, Lars Gustav Lyckander, Helene Knævelsrud, Lars Eftang, Anne Simonsen   +9 more
wiley   +1 more source

Experimental evaluation of dermal lymphatics in preservation of lymphatic function. [PDF]

Breast Cancer Res
Hulsman L, Mohan G, Sidhu AS, Ahmed S, Sullivan SJ, Subi-Kasozi CA, Mahariq AR, Jorge MD, Sinha M, Hassanein AH.   +9 more
europepmc   +1 more source

USING VOSVIEWER SOFTWARE IN COLLECTING MATERIALS OF OVERVIEW RESEARCH

Le Thi Tu Oanh, Hoang Thanh Hanh, Le Thi Minh Phuong, Pham Thi Hong Nhung   +3 more
openalex   +2 more sources

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

Molecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata, Koji Ando, Hirofumi Hasuda, Koshi Mimori, Elizabeth C. Unan, Siddhartha Pulukuri, Aahana Tiku, Allison Berger, Eiji Oki, Ajit Bharti, Tomoharu Yoshizumi   +10 more
wiley   +1 more source

Congenital Renal arteriovenous malformation: An unusual cause of clot retention - Case report and review of the literature. [PDF]

Urol Case Rep
Nordin N, McCoy R, Brown S, Gopal N.
europepmc   +1 more source

DNA methylation and expression of MAPRE3 affect overall survival of early‐stage non‐small cell lung cancer patients

Molecular Oncology, EarlyView.
Both cg12821679MAPRE3 methylation and MAPRE3 expression are significantly associated with overall survival (OS) of non‐small cell lung cancer. Meanwhile, MAPRE3 expression significantly modified the effect of smoking cessation on OS. Smoking cessation benefits OS merely for patients with high MAPRE3 expression.
Chao Chen, Jiancheng Cheng, Ruili Hou, Xiaoyuan Zheng, Li Su, Maria Moksnes Bjaanæs, Anna Karlsson, Maria Planck, Johan Staaf, Åslaug Helland, Manel Esteller, David C. Christiani, Feng Chen, Xiaofei Cao, Ruyang Zhang   +14 more
wiley   +1 more source

Clear cell renal cell carcinoma with collecting duct carcinoma transformation: a case report and review of the literature. [PDF]

BMC Urol
Liang M, Li L, Cao Y, Zhang K, Fu Q.
europepmc   +1 more source

Welfare indicators in bulls submitted to collect of semen by eletroejaculation.

, 2009
Wolff Camargo Marques Filho, Jair Camargo Ferreira, C. J. Fugihara   +2 more
openalex   +1 more source

Circulating tumor cell viability during and after radiotherapy mirrors treatment response in cancer patients

Molecular Oncology, EarlyView.
Radiotherapy (RT) response depends on the DNA repair capacity of tumor and host cells. We show that circulating tumor cell (CTC) counts and apoptosis rates before and after RT predict treatment response and outcome, which can be accessed via easily accessible liquid biopsy approaches. Created in BioRender. Wikman, H.
Yvonne Goy, Jana Löptien, Cornelia Coith, Afroditi Nanou, Katharina Hintelmann, Pinnschmidt Hans, Cordula Petersen, Klaus Pantel, Sabine Riethdorf, Kerstin Borgmann, Harriet Wikman   +10 more
wiley   +1 more source